Skip to content

Company information lookup


Clinical-stage pharmaceutical drug development

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IVX 0.067 -4.29% 0.067 0.070 0.070 0.070 0.067 546,757


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IVX
Official Listing Date 15 February, 2010
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address
Registered Office Address c/- McCullough Robertson Lawyers, Level 11, 66 Eagle Street, Brisbane, QLD, AUSTRALIA, 4000
Head Office Telephone +61 7 3295 0500
Head Office Fax +61 7 3295 0599
Share Registry Telephone 1300 554 474
Directors / Senior Management
Dr Ralph Craven (Chairman)
Dr Greg Collier (Managing Director, CEO)
Dr Mitchell Glass (Executive Director)
Mr Warren Brown (Non Exec. Director)
Dr James Campbell (Non Exec. Director)
Mr Brett Heading (Non Exec. Director)
Company Secretary Ms Melanie Farris
Principal Activities Clinical-stage pharmaceutical drug development

INVION LIMITED announcements

How are company announcements published on

Date Price
Headline Pages PDF
09/04/2014   Invion presentation to BIO Asia Tokyo 30 PDF
09/04/2014   MD and CEO Dr Collier presents at BIO Asia Tokyo 1 PDF
02/04/2014   Change of Directors Interest Notice (R Craven) 2 PDF
02/04/2014   Change of Director's Interest (G Collier) 3 PDF
02/04/2014   Change of Directors Interest Notice (M Glass) 2 PDF
02/04/2014   Change of Director's Interest (J Campbell) 3 PDF
02/04/2014   Change of Directors Interest Notice (B Heading) 2 PDF
02/04/2014   Change of Director's Interest (W Brown) 3 PDF
28/03/2014   Completion of Rights Issue and Notice of shortfall 2 PDF
28/03/2014   Appendix 3B shares to be issued under Rights Issue 12 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.067 -4.29% 0.070 0.067 546,757
16 Apr 2014 0.070 0% 0.071 0.069 403,250
15 Apr 2014 0.070 0% 0.072 0.070 130,026
14 Apr 2014 0.070 -2.78% 0.073 0.070 238,849
11 Apr 2014 0.072 4.35% 0.072 0.070 178,976

* Volume of shares shown represents only those shares traded on ASX.

INVION LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security IVX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IVX

Warrants & Structured Products

No warrants & Structured Products are available over the security IVX


No Contracts For Differences are available over the security IVX